NCT05320458

Brief Summary

The aim of our study is to investigate the effects of pulmonary rehabilitation on respiratory tests and quality of life in patients with early and locally advanced NSCLC who received chemotherapy regardless of whether the investigators had undergone surgical treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
11

participants targeted

Target at below P25 for not_applicable lung-cancer

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

May 2, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2022

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

2 months

First QC Date

February 25, 2022

Last Update Submit

April 1, 2022

Conditions

Keywords

Lung CancerPulmonary RehabilitationAerobic ExercisePhysiotherapy and RehabilitationOncological Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Chance from baseline in posture analysis score

    Posture score is going to be assess by posture analysis form to determine change from baseline.

    8 week

Secondary Outcomes (1)

  • Physical Activity Level

    8 week

Study Arms (1)

Pulmonary Rehabilitation

EXPERIMENTAL

Pulmonary rehabilitation program will be applied 3 days a week at 40-60% of submaximal heart rate for a total of 8 weeks. Diaphragmatic breathing, pursed lips and segmental breathing exercises will be applied to the patients in the presence of a physiotherapist. Walking and aerobic exercise training will be given.

Other: Pulmonary Rehabilitation

Interventions

1-Pulmonary Rehabilitation: Pulmonary rehabilitation program was applied at 40-60% of submaximal heart rate, 3 days a week for a total of 8 weeks. Diaphragmatic breathing, pursed lip breathing and segmental breathing exercises were practiced with the patients in the company of a physiotherapist. Walking and aerobic exercise training was given.

Pulmonary Rehabilitation

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18-65, must be in remission.
  • Surgery, adjuvant chemotherapy and radiotherapy processes must be completed.

You may not qualify if:

  • Those with suspected pregnancy
  • Diabetes mellitus diagnosis
  • Patients in the metastatic period
  • Patients with a diagnosis of acute/chronic infection were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasan Kalyoncu Univercity

Gaziantep, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung NeoplasmsSmall Cell Lung Carcinoma

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single group 30 individuals were included in the study. Surgery, adjuvant chemotherapy and radiotherapy processes of all patients included in the study were completed. Patients between the ages of 18-65 and in remission period were included in the study. Patients with suspected pregnancy, diabetes mellitus, metastatic patients, and patients with acute and chronic infections were excluded from the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

February 25, 2022

First Posted

April 11, 2022

Study Start

May 2, 2022

Primary Completion

July 1, 2022

Study Completion

September 2, 2022

Last Updated

April 11, 2022

Record last verified: 2022-04

Locations